Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allofit® IT With HXPE in Total Hip Arthroplasty. A Multi-center, Prospective, Non-controlled Post Market Surveillance Study

NCT03672929 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT03672929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03672929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allofit® IT With HXPE in Total Hip Arthroplasty. A Multi-center, Prospective, Non-controlled Post Market Surveillance Study
Lead sponsor
Zimmer Biomet
Phase
Observational
Overall status
Completed
Start date
June 5, 2011
Completion date
July 3, 2025
Enrollment
197 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis, inflammatory arthritis, osteoarthritis, hip, post-traumatic osteoarthritis of hip